Original from: GlobeNewswire
AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott¡¯s point-of-care testing products through the HealthTab™ platform in the UK.
The agreement allows HealthTab to distribute Abbott¡¯s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. ¡°This agreement represents our most significant milestone to date,¡± said Rodger Seccombe, CEO of Avricore Health. ¡°We¡¯ve spent fifteen years building and proving the model for pharmacy-based point-of-care testing, and we¡¯ve learned that solving this problem takes more than great technology ¡ª it takes an industry-leading partner willing to invest the people, expertise, and resources needed to make it successful. We couldn¡¯t have asked for a better team to be working with, and together we¡¯re going to make a real impact on patient care.¡±
HealthTab™ at the Core of Scalable, Integrated PoCT
HealthTab™ provides a complete, turnkey solution underpinning national pharmacy-based PoCT networks, including best-in-class instruments, consumables, onboarding, training, and ongoing support for participating sites.
At its centre is a secure cloud-based platform that seamlessly connects point-of-care analyzers, patient results, QC data, and pharmacist workflows, creating a unified digital infrastructure for community-based testing.
This integrated approach ensures quality-assured testing, consistent data capture across locations, and real-time analytics to support public-health reporting and performance monitoring, while reducing implementation complexity for pharmacy partners.
